Purpose (Chapter Two of My Best Advice: Proven Rules for Effective Leadership)

Think about how you spent the past day, week, or even month. Why did you spend it that way? Why did you invest your time the way you did? Did you go to work? Why do you go to work every day? Did you go to your daughter\u27s recital or your son\u27s play? Why? Did you get some exercise? Did you take your partner to lunch? Did you go to the neighborhood barbecue? Why? On the surface, our answers to these questions may be simple: I go to work to make money so I can pay my bills and support a certain lifestyle for my family. I go to my kids\u27 events to support them. I love my partner. I enjoy spending time with my neighbors. There may be deeper drivers for each of these decisions as well

Globalization: History Repeats (Chapter 1 from Distributed Team Collaboration in Organizations: Emerging Tools and Practices)

The strategy to improve business results through globalization has become increasingly common. Success in reaping the business value intended from a globalization strategy is, unfortunately, not as common. As national boundaries blur and everyone grows more connected through global collaboration, the dynamics of organizational life grow more complex. These complexities offer challenge, confusion, and frustration – but also great opportunity! The key to achieving improved business results does not hinge on strategies alone, but also on our ability to effectively lead global product and service development teams to successfully execute the strategies. Those struggling the most are the practitioners who find their historic team leadership practices ineffective in today’s global business model. To effectively lead a global team, one must first understand the forces driving our companies to a global business model. This chapter focuses on the forces that fuel and constrain globalization

Program Manager Competencies (Chapter 11 of Program Management for Improved Business Results)

The successful program manager is constantly seeking to learn and broaden his or her knowledge and experience in order to take on more complex and critical programs. The program management competency model was developed in order to address the breadth, depth, and complexity of the program management role. This chapter uses the program management competency model to detail the knowledge, skills, and abilities needed for program managers to continually grow as professionals and consistently succeed in their role. The various types of competencies that are discussed in the chapter are: customer and market competencies, business and financial competencies, process and project management competencies, and leadership competencies. Additionally, the chapter discusses the key organizational enablers needed to make the competency model fully effective and to adequately support the program management discipline within an organization

CMS physics technical design report : Addendum on high density QCD with heavy ions

Peer reviewe

Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study

PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19–free surgical pathways. Patients who underwent surgery within COVID-19–free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score–matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19–free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19–free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks